Virinchi Share Price Today

Virinchi shareholders approve all resolutions at 37th AGM with strong majority

All resolutions at Virinchi's 37th AGM passed with requisite majority. FY26 financial statements adopted with 99.92% votes in favour. V. Satyanarayana re-appointed as Director with 99.83% support. Total votes polled across both resolutions stood at 16,464,513. No invalid votes recorded during the e-voting process.

Virinchi dispatches FY26 annual report ahead of September 30 AGM

Virinchi Limited dispatched its FY26 annual report to shareholders in compliance with SEBI regulations. The 37th AGM is scheduled for September 30, 2026, at 12:30 pm via video conferencing. Key agenda includes adoption of audited financial statements and re-appointment of director V. Satyanarayana. Remote e-voting opens on September 26, 2026, with a cut-off date of September 23, 2026.

Virinchi Ltd schedules 37th AGM for September 30, approves FY26 reports

Virinchi Limited scheduled its 37th AGM for September 30, 2026. The meeting will be held via VC/OVAM mode. Board approved the Board Report for FY26. Mr. Satyanarayana Vedula was re-appointed as director.

Virinchi shareholders approve Bristlecone Hospitals acquisition

Virinchi Limited secured shareholder approval for acquiring the Bristlecone Hospitals business from its subsidiary via a postal ballot. The resolution passed with 95.13% support from public non-institutional investors, while promoters abstained. The slump sale structure facilitates the consolidation of healthcare assets into the parent company.

Virinchi Ltd revises audited annual results for FY26

Virinchi Ltd revised its audited financial results for the quarter and year ended March 31, 2026, correcting errors in standalone EPS, segment details, and consolidated PAT and EPS figures.

Virinchi Ltd shareholders approve loans and related party transactions

Virinchi Limited secured shareholder approval on July 14, 2026, for loans under Section 185 of the Companies Act, 2013, and for material related party transactions with Virinchi Health Care Private Limited and Vivo Bio Tech Limited. The resolutions were passed via postal ballot with over 90% support from public non-institutional shareholders, while promoter and institutional categories did not participate.